Maharashtra FDA Cancels Licence Of Cipla Pharma’s Pune Unit, Seizes Rs 11.19 Lakh Drug Stock
Maharashtra FDA cancels Cipla’s Pune unit drug sale licence over Reactin Plus-related irregularities and seizes stock worth Rs 11.19 lakh.
Read Full Story on Source